Publications by authors named "R Diaz-Mancebo"
Article Synopsis
- Acute kidney injury (AKI) is a common complication in hospitalized COVID-19 patients, worsened by underlying health issues; the Spanish Society of Nephrology launched the AKI-COVID Registry to collect data and analyze outcomes for these patients.
- A study of 730 patients revealed that most were older, predominantly men, and had high rates of hypertension and diabetes; many required ventilatory support, with a notable 33.9% needing renal replacement therapy (RRT) during hospitalization.
- Key predictors for needing RRT included smoking, the requirement for ventilatory support, and higher maximum creatinine levels; overall, 38.6% of patients died in the hospital, with more severe AKI
Background And Objectives: Acute kidney injury (AKI) is common among hospitalized patients with COVID-19 and associated with worse prognosis. The Spanish Society of Nephrology created the AKI-COVID Registry to characterize the population admitted for COVID-19 that developed AKI in Spanish hospitals. The need of renal replacement therapy (RRT) therapeutic modalities, and mortality in these patients were assessed.
View Article and Find Full Text PDFThrombotic microangiopathy associated with use of interferon-beta.
Int J Nephrol Renovasc Dis
October 2012
Interferon-beta is widely used for the treatment of relapsing multiple sclerosis. The drug is usually well tolerated, but autoimmune adverse effects, including kidney disease, have been reported. Only a few cases of hemolytic uremic syndrome-thrombotic microangiopathy associated interferon-alpha have been described so far, and even fewer with beta-interferon.
View Article and Find Full Text PDF